Using a novel metric that links investment in drug research and development (R&D) to output in terms of revenue from the resultant drugs, this article analyses trends in R&D productivity overall and in specific therapeutic areas, and discusses strategies for improvement.
- Katarzyna Smietana
- Leeland Ekstrom
- Martin Møller